Clifford Chance and Sullivan & Cromwell are leading a group of firms on buy-out house Cinven’s sale of UK-based pharmaceuticals company Amdipharm Mercury (AMCo).
Canada-based Concordia Healthcare has entered into a deal with Cinven to acquire AMCo for $3.5bn (£2.27bn).
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
